Elos Medtech Interim Report January 1 - September 30, 2019
INCREASED PROFITABILITY THROUGH EFFICIENCIES July - September 2019 • Net sales for the third quarter increased to SEK 157.1 (154.1) million, which corresponds to organic growth of 1.9 percent. Taking into account currency conversions, growth was negative, -1.3 percent.• The operating profit was SEK 14.2 (11.8) million. Our operating margin for the third quarter of 2019 was 9.0 percent, up from 7.7 percent in the same period in 2018.• The profit after financial items was SEK 11.4 (7.7) million. Net financial items, which were not affected by exchange rate differences during the